AKT1 and lung carcinoma: The integration of the above GO and KEGG data indicates that the 6 hub targets are mainly enriched in the ErbB signaling pathway and PI3K-Akt signaling pathway, thereby associating significantly with the anti-lung cancer activity of 18-αGA.